eFFECTOR Therapeutics effector.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1133)

eFFECTOR Therapeutics is an early stage company focused on the discovery and development of new small molecule cancer therapeutics. eFFECTOR is developing translation regulators to selectively block disregulated translation impacting tumor growth and survival. The company has selected control of mRNA translation as a key point of theerapeutic intervention, providing potency and selectivity while inhibiting growth of cancer cells. eFFECTOR's approach provides a real opportunity to bring new medic...Show all

eFFECTOR Therapeutics is an early stage company focused on the discovery and development of new small molecule cancer therapeutics. eFFECTOR is developing translation regulators to selectively block disregulated translation impacting tumor growth and...Show all

Company (Alive / Active)

All investors data 14 Investors

Phone: 858-442-4861

Fax:

11180 Roselle Street
Suite A
 San Diego, 92121
 California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
eFFECTOR Therapeutics $139.6M Jul 24, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related eFFECTOR Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors

Board Members

Name Firm
Login to see detailsNew Enterprise Associates
Login to see detailsSR One
Login to see detailsAbingworth
Login to see detailsThe Column Group
Login to see detailsNovartis Venture Funds
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Eif4a-inhibiting compounds and methods related thereto Nov 22, 2016 May 01, 2018 Patent
Mnk inhibitors and methods related thereto Jun 02, 2017 Nov 14, 2017 Patent
Mnk inhibitors and methods related thereto Jun 21, 2016 Jun 06, 2017 Patent
Mnk inhibitors and methods related thereto Nov 10, 2017 Application
Mnk biomarkers and uses thereof Dec 23, 2016 Application
See all 11 patents